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Micacocidin is a thiazoline-containing natural pro-
duct from the bacterium Ralstonia solanacearum
that shows significant activity against Mycoplasma
pneumoniae. The presence of a pentylphenol moiety
distinguishes micacocidin from the structurally
related siderophore yersiniabactin, and this residue
also contributes to the potent antimycoplasma
effects. The biosynthesis of the pentylphenol moiety,
as deduced from bioinformatic analysis and stable
isotope feeding experiments, involves an iterative
type I polyketide synthase (iPKS), which generates
a linear tetraketide intermediate from acyl carrier
protein-tethered hexanoic acid by three consecu-
tive, decarboxylative Claisen condensations with
malonyl-coenzyme A. The final conversion into
6-pentylsalicylic acid depends on a ketoreductase
domain within the iPKS, as demonstrated by heterol-
ogous expression in E. coli and subsequent site-
directed mutagenesis experiments. Our results
unveil the early steps in micacocidin biosynthesis
and illuminate a bacterial enzyme that functionally re-
sembles fungal polyketide synthases.
INTRODUCTION
Mycoplasma pneumoniae is one of the leading causes of com-
munity-acquired pneumonia and other respiratory disorders.
Due to the lack of a cell wall, this bacterium is naturally resistant
against beta-lactam and glycopeptide antibiotics. Since the
pathogen also exhibits enhanced resilience against aminoglyco-
sides, oxazolidinones, rifampicin, and sulfonamides, therapy of
M. pneumoniae infections is restricted to a limited set of anti-
biotics, among which macrolides are typically considered the
drugs of first choice (Waites and Talkington, 2004). Of note,
macrolides also represent the only agents that are approved
for the treatment of M. pneumoniae infections in children.
Over the past decade, the prevalence of macrolide-resistant
M. pneumoniae strains has dramatically increased (Jacobs,
2012), and more recently, several cases of resistance emerging764 Chemistry & Biology 20, 764–771, June 20, 2013 ª2013 Elsevierunder macrolide therapy have been described (Averbuch et al.,
2011; Cardinale et al., 2011; Itagaki et al., 2013).
Micacocidin is a new antibiotic that exerts strong inhibitory
effects in the nanomolar range against several Mycoplasma
species, including M. pneumoniae (Kobayashi et al., 1998).
In vivo efficacy after oral administration was demonstrated in
chicken that had been infected withM. gallisepticum (Kobayashi
et al., 2000). The thiazoline-containing natural product micaco-
cidin is structurally closely related to the siderophore yersinia-
bactin (Drechsel et al., 1995), and cellular uptake studies
suggest that it might also be involved in iron acquisition of the
producing bacterium Ralstonia solanacearum (Kreutzer et al.,
2011). It is interesting that the antimycoplasma activity of mica-
cocidin is not linked to its metal-chelating properties, as an
iron(III)-loaded complex exhibits the same level of activity as
the free ligand (Kobayashi et al., 2000). Furthermore, blockage
of the metal coordination sites by chemical modification does
not affect the growth-inhibitory effects against Mycoplasma
species (Ino et al., 2001).
A recent study unveiled the polyketide synthase (PKS) and
nonribosomal peptide synthetase (NRPS) genes that account
for the assembly of micacocidin (Kreutzer et al., 2011). Even
though the domain architecture of the corresponding biosyn-
thesis enzymes is highly reminiscent of the yersiniabactin
assembly line (Gehring et al., 1998b; Miller et al., 2002), some
minor deviations were found to be sufficient to translate into
chemical diversity (Figure 1). Both yersiniabactin and micacoci-
din feature a phenolic moiety in their structures, but in the case
of micacocidin, the corresponding residue is further decorated
with a pentyl side chain. This structural variation apparently
has important consequences in terms of biological activity
(Takeda et al., 1996), fueling the interest in its biosynthetic origin.
The phenolic moiety in yersiniabactin derives from salicylic acid,
which was shown to be incorporated by the stand-alone AMP-
dependent ligase YbtE (Gehring et al., 1998a). In themicacocidin
pathway, the adenylation domain MicC-A1 represents the enzy-
matic counterpart of YbtE. However, the sequence of MicC-A1
exhibits a specificity-conferring signature that appears to be
inconsistent with the loading of an aryl carboxylic acid (Stachel-
haus et al., 1999; May et al., 2002). Moreover, the presence of an
additional type I PKSmodule, which is absent in the yersiniabac-
tin assembly line, was puzzling. Intrigued by these peculiarities,
we set out to resolve the molecular mechanism by which the
pentylphenol moiety of micacocidin is formed. The knowledgeLtd All rights reserved
Figure 1. Modular Biosynthesis Enzymes
for the Production of Micacocidin
(A) Domain architecture of the micacocidin (Mic)
assembly line. Domains that likely account for
the structural differences to yersiniabactin (Ybt)
are highlighted in blue. Domain notation: A,
adenylation; ACP, acyl carrier protein; KS, keto-
synthase; AT, acyl transferase; KR, ketor-
eductase; C, condensation; MT, SAM-dependent
methyltransferase; PCP, peptidyl carrier protein;
TE, thioesterase.
(B) Chemical structures of micacocidin and
yersiniabactin.
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duction and generate structural derivatives of this promising
antibiotic.
RESULTS AND DISCUSSION
Identification of the Starter Unit in Micacocidin
Biosynthesis
Feeding studies with stable isotope precursors revealed that the
metabolic origin of the pentylphenol moiety is dissimilar from the
salicylate building block in yersiniabactin. While the latter derives
from shikimate metabolism (Gehring et al., 1998a), the incorpo-
ration pattern of 13C-labeled acetate into micacocidin was in
full agreement with a polyketide origin (Figure S1 available
online). It paralleled that of the plant metabolite olivetolic acid
(4-hydroxy-6-pentylsalicylic acid), which is an important inter-
mediate in the pathway to cannabinoids (Fellermeier et al.,
2001). The biosynthesis of olivetolic acid involves a type III
PKS, which forms a linear tetraketide from hexanoyl-coenzyme
A (CoA) and three molecules of malonyl-CoA (Taura et al.,
2009). Conversion of the tetraketide into olivetolic acid was not
solved until recently, when a cyclase was found to catalyze the
concluding intramolecular aldol condensation (Gagne et al.,
2012). Based upon the results from the feeding studies in
R. solanacearum, an analogous mechanism for the formation
of 6-pentylsalicylic acid (PSA) would be conceivable, yet the
entire genome of the micacocidin producer is devoid of genes
for type III PKSs (Salanoubat et al., 2002). Therefore, we envis-
aged two alternative scenarios that could give rise to PSA and
that are compatible with the experimentally observed incorpora-
tion of acetate units, as well as the domain organization of the
micacocidin biosynthesis enzymes. The first scenario assumes
an activation of hexanoic acid by MicC-A1 and transfer as acyl-
adenylate on to the assembly line prior to acyl chain elongation,
ring formation, and aromatization. It is obvious that the elonga-
tion implies an iterative usage of the PKS module in MicC,
which is reminiscent, to a degree, of fungal type I PKSs with an
N-terminal starter unit-acyl carrier protein (ACP) transacylase
domain (Crawford et al., 2006; Zhou et al., 2008; Crawford andChemistry & Biology 20, 764–771, June 20, 2013Townsend, 2010). In the second sce-
nario, we proposed the loading of an
oxygenated decanoic acid, which would
undergo a single decarboxylative thio-
Claisen condensation with malonyl-CoA
to give a C12 diketide. Again, an aldol-type reaction could cyclize the thioester-bound intermediate,
which would then be further oxidized to PSA.
In order to distinguish between the two routes, the loading
module of MicC was heterologously produced and purified
from Escherichia coli KRX as an N-terminal hexahistidine fusion
via the pET28a(+)-derived expression plasmid pHiK007 (Fig-
ure S2; for primer sequences, see Table S1). The substrate
preference of the recombinant protein was tested in the ATP-
[32P]-pyrophosphate exchange assay, as previously described
(Kreutzer et al., 2012). This approach revealed a clear preference
for hexanoic acid, whereas the other possible starter molecule,
decanoic acid, was not activated at relevant levels (Figure 2).
Further testing showed a narrow substrate tolerance of the
enzyme. While pentanoic acid and heptanoic acid could still be
converted into their corresponding adenylate products with
low efficiency, octanoic acid already failed to give an appreciable
response. A subsequent feeding study in R. solanacearum with
[1-13C]hexanoic acid led to an increased incorporation of label
at C-3 of micacocidin (Figure S1), ultimately confirming this
short-chain fatty acid as the biosynthetic starter unit.
Heterologous Production of PSA in Escherichia coli
To investigate whether the PKS module of MicC catalyzes the
proposed iterative C2 chain elongation of primed hexanoic
acid, a truncated enzyme including the loading and the first
extender module (A1-ACP-KS-AT-KR-ACP) was recombinantly
produced. The assembly of the respective expression vector,
pHiK008, was accomplished by l Red-mediated in vivo cloning
(Zhang et al., 2000; Figure S3). For gene expression, pHiK008
was introduced into E. coli BL21(DE3). Although the genome of
E. coli harbors the genes for at least three different phosphopan-
tetheinyl transferases (PPTases), the substrate selectivity of
these enzymes is known to be a bottleneck for the heterologous
biosynthesis of polyketide natural products (Lambalot et al.,
1996; Pfeifer and Khosla, 2001). The micacocidin biosynthesis
locus includes a putative PPTase gene, micA, which was
hence expected to represent the cognate enzyme for the
posttranslational activation of the acyl and peptidyl carrier pro-
teins in the micacocidin assembly line. High-performance liquidª2013 Elsevier Ltd All rights reserved 765
Figure 2. Substrate Preference of the MicC Loading Module
Degree of exchange in the ATP-[32P]-pyrophosphate assay with various test
substrates. cpm, counts per minute. Bars represent SD. See also Figure S2.
Chemistry & Biology
An iPKS Initiates Micacocidin Assemblychromatography-mass spectrometry (HPLC-MS) analysis of
E. coli expression cultures confirmed that PSA is only heterolo-
gously produced at relevant levels when micC (A1-ACP-KS-
AT-KR-ACP) is coexpressed with micA (Figure 3). Evidence for
the production of olivetolic acid was not found. It is interesting
to note that the tetraketide, which had been synthesized on a
truncated assembly line, was readily hydrolyzed to give free
PSA. With a size of 834 amino acids and a molecular weight of
almost 90 kDa, the protein MicA is significantly larger than other
PPTases (Lambalot et al., 1996; Sa´nchez et al., 2001). This size
expansion is due to the presence of a type II thioesterase (TE)
domain (Figure S4; Table S2) that is located N-terminal of the
PPTase domain. MicA may hence provide hydrolytic activity,
which would contribute to the offload of the polyketide from
the assembly line and the concomitant regeneration of MicC.
Functional Analysis of MicA, a Bifunctional Protein with
TE and PPTase Domains
To evaluate whether the release of the thioester-bound interme-
diate in the coexpression experiment is at least partially medi-
ated by MicA, the serine in the active site of its TE domain was
replaced with alanine by site-directed mutagenesis. Analysis of
the MicA protein sequence had previously revealed the
consensus sequence with the serine residue, which is respon-
sible for acyl-O-enzyme intermediate formation in TEs (Hardie
et al., 1985). As shown in Figure 3, PSA was still detected in
the TE mutant with S417A substitution, although at drastically
lower quantities (1.5%) in comparison to the E. coli strain ex-
pressing native micA. This finding supports the proposed dual
function and the significance of MicA in the heterologous pro-
duction of PSA.
In order to interrogate the importance ofmicA for micacocidin
biosynthesis, the gene was disrupted in the R. solanacearum
producer strain GMI1000 by allelic-exchange mutagenesis (Fig-
ure S5). It is surprising thatmicA turned out to be dispensable for
the assembly of the natural product, as the production was still
active in the micA-defective mutant strain RS7, albeit at sig-
nificantly reduced levels (Figure 4).We assume that this outcome
is largely due to the inactivation of the PPTase function of micA,
which was only partially complemented by redundant PPTase
genes, as described in kirromycin biosynthesis (Pavlidou et al.,766 Chemistry & Biology 20, 764–771, June 20, 2013 ª2013 Elsevier2011). Two potential candidates in the R. solanacearum genome
that could substitute the missing PPTase gene are RSc1067
and RSp0163, respectively. On the other hand, the loss of
the TE function from micA was possibly less important than
in the preceding heterologous expression experiment. In
R. solanacearum, the type I TE domain from the NRPS MicH is
expected to be responsible for the release of the fully assembled
natural product, whereas the TE domain of MicA would merely
serve an editing function to remove aberrant molecules from
the enzyme complex (Miller et al., 2010). The fact that no stalled
intermediates were retrieved from R. solanacearum RS7 could
be attributed to the generally low micacocidin production level
of the mutant.
Effects of Ketoreductase Domain Inactivation on PSA
Biosynthesis
Ketoreductase (KR) domains of iterative type I PKSs (iPKSs) are
known to act regiospecifically during polyketide chain extension,
thereby setting the substitution pattern of the final product (Hert-
weck, 2009; Sun et al., 2012; Chooi and Tang, 2012). To deter-
mine the role of the KR domain in MicC, we chose to mutate
the highly conserved Tyr residue in its active center (correspond-
ing to Y1991). The latter is part of a catalytic triad together with
Lys and Ser residues (Jo¨rnvall et al., 1995; Oppermann et al.,
1997), and existing models suggest that the tyrosine transfers
a phenolic proton to the b-carbonyl oxygen atom during
the reduction process (Caffrey, 2003). Mutagenesis studies
confirmed the fatal effects of amino acid substitutions at this
site, which can result in the synthesis of lactone shunt products
(Reid et al., 2003). We initially replaced Y1991 with phenylala-
nine, as this amino acid should maintain the active site geometry
while eliminating the required hydroxyl group for catalysis (Ding
et al., 2010). Moreover, Y1991 was mutated to alanine, which
would definitely shut down the KR activity in MicC. The genes
carrying the mentioned mutations were expressed in E. coli
BL21(DE3) together with micA, as previously described. In
both cases, no PSA could be detected in the culture superna-
tant of the heterologous host. Instead, the occurrence of a new
peak was observed. The high-resolution mass of this metabolite
at m/z 223.0976 [M-H] indicated a molecular formula of
C12H15O4, which would be consistent with either a lactoniza-
tion-derived pyrone or olivetolic acid. The latter possibility could
be excluded after cochromatography with an authentic standard
(Figure 3). In the absence of a functional reductive domain, the
iPKS thus generated a linear tetraketide that is prone to intramo-
lecular lactonization upon keto-enol tautomerism.
Model for the Biosynthesis of the PSA-Derived
Pentylphenol Moiety in Micacocidin
The result from the mutation study corroborated that the KR
domain of MicC is essential for the assembly of PSA. In analogy
to the biosynthesis of 6-methylsalicylic acid (MSA) in bacteria
and fungi, we propose that MicC-KR exclusively reduces the
b-keto function at the stage of the triketide intermediate. Inacti-
vation of the KR domain did not halt the polyketide chain elonga-
tion, suggesting an enhanced tolerance of MicC-ketosynthase
with regard to b functionality recognition. The nonreduced tetra-
ketide was not converted into olivetolic acid, as expected, but
likely underwent lactonization to give an a-pyrone (Figure 5).Ltd All rights reserved
Figure 3. Functional Validation ofmicC and
micA in E. coli
Stacked extracted ion chromatograms for masses
corresponding to them/z of PSA (2) and the shunt
pyrone (3) produced by E. coli cultures expressing
micC (A1-ACP-KS-AT-KR-ACP) (a); micC and the
TE-PPTase gene micA (b); micC and the TE
mutant of micA with S417A (c); micA and the
KR mutant of micC with Y1991A (d);micA and the
KR mutant of micC with Y1991F (e); or standard
olivetolic acid (f). To distinguish 3 from olivetolic
acid (4), the samples in (d) and (e) had been spiked
with 1 mmol of the latter prior to HPLC-MS anal-
ysis. Identification of the peaks was achieved by
measuring the accurate mass and calculation of
the chemical formula within a 5 ppm range (2:m/z
207.1022 [M-H], C12H15O3; 3 and 4: m/z
223.0979 [M-H], C12H15O4). t/min, retention time
in minutes. See also Figure S3.
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the NADPH binding site of their KR domains were mutated (Mor-
iguchi et al., 2008; Richardson et al., 1999). In contrast, the native
MicC assembles a correctly processed d-hydroxylated tetrake-
tide intermediate that cyclizes upon intramolecular C2-C7 aldol
condensation. It is obvious that the aromatization to the PSA
moiety requires an elimination of the d-hydroxy group. The cor-
responding dehydration reaction may occur spontaneously, as
proposed in the formation of MSA and islandicin, respectively
(Moriguchi et al., 2010; Scha¨tzle et al., 2012). Even though the
precise timing of aromatization and cyclization remain to be
determined, the heterologous expression experiment estab-
lished the minimal biochemical basis for the formation of PSA,
i.e., the first two modules of holo-MicC.
In summary, MicC has been identified as 6-pentylsalicylate
synthase and, by site-specific mutagenesis, the necessity of its
KR domain for correct substrate processing is provided. We
expect that this knowledge may eventually help generate struc-
tural derivatives of the antimycoplasma agent micacocidinChemistry & Biology 20, 764–771, June 20, 2013through genetic engineering of the
producer strain. From a biochemical
perspective, MicC is highly interesting,
as it combines features from the function-
ally distinct partially reducing and nonre-
ducing iterative PKSs (Cox, 2007), which
are only rarely found in bacteria (Gaisser
et al., 1997). The exclusive production
of PSA, but not of olivetolic acid, by
MicC is suggestive of regioselective ke-
toreduction, as observed in partially
reducing PKSs (Sun et al., 2012; Lu
et al., 2011; Sthapit et al., 2004; Zhao
et al., 2008). These monomodular en-
zymes, however, are encoded by discrete
genes, and they also exhibit a conserved
thioester hydrolase (TH) domain for
product release (Moriguchi et al., 2010).
Both features are not applicable to the
PKS in MicC, even though the lack ofthe TH domain can be easily rationalized. Another discrepancy
involves the mode of initiating ketide chain formation. While
partially reducing PKSs typically use acetyl-CoA as a starter
unit, the MicC PKS is loaded via intraprotein transfer from an
N-terminal ACP domain. Except for bacterial (noniterative)
modular type I PKSs (Gulder et al., 2011), a related starter unit
selection is only known from fungal nonreducing PKSs, which,
however, completely lack reductive domains (Crawford et al.,
2006; Zhou et al., 2008).
SIGNIFICANCE
Micacocidin is a thiazoline-containing natural product with
pronounced activity against the human pathogen Myco-
plasma pneumoniae. Although its biosynthetic assembly
line reflects the close relationship to the siderophore yersi-
niabactin, the molecular basis for the subtle, yet biologically
important, structural differences were not clear. Biochem-
ical analyses of the early steps in micacocidin biosynthesisª2013 Elsevier Ltd All rights reserved 767
Figure 4. Metabolic Characterization of the
micA Mutant Strain RS7
Chromatographic profiles of R. solanacearum
GMI1000 (A) and the micA-deficient mutant strain
RS7 (B) recorded at 254 nm. The production of
micacocidin is substantially reduced in the mutant
strain RS7 (<1% of wild-type level), but not
completely abolished.
See also Figure S5.
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PKS that is integrated into a multimodular assembly line.
Mechanistically, the protein seems to be related to partially
reducing iterative PKSs, which utilize programmed ketore-
duction to direct the biosynthesis toward a defined, aro-
matic product. On the other hand, the primary amino acid
sequence, the domain organization, and also the starter
unit selection of the micacocidin iPKS are clearly distinct,
making this enzyme a promising candidate for further
biochemical studies. The described findings set the stage
for the rational engineering of more potent micacocidin
analogs. Furthermore, the possibility to independently
reconstitute the assembly of the micacocidin precursor
6-pentylsalicylate in E. coli may prove useful in the field of
combinatorial biosynthesis.EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions
The Ralstonia solanacearum wild-type strain GMI1000 and the mutant
strain RS7 were grown at 30C in BG medium (15 g/l Bacto-Agar, 5g/l
glucose) or modified 1/4 3 M63 minimal medium supplemented with
0.2% glucose and 0.02% sodium acetate (Schneider et al., 2009). The
mutant strain RS7 was continuously kept under antibiotic selection pressure
(20 mg/ml kanamycin). Escherichia coli strains were routinely grown in Luria
broth (LB) medium. For protein expression experiments, Terrific broth (TB)
was used.Incorporation Studies of Isotopically Labeled Precursors
All feeding experiments were conducted in 5 l Erlenmeyer flasks containing
1 l of iron-deficient 1/4 3 M63 minimal medium according to a previously
established protocol (Wackler et al., 2011). Briefly, 13C-labeled precursors
were added aseptically at time of inoculation as filter-sterilized aqueous
solutions: [1-13C]acetate (50 mg/l) or [1-13C]hexanoate (50 mg/l). The cul-
tures were shaken for 3 days at 30C. For the recovery of micacocidin, the
culture broth was extracted twice with ethyl acetate. The combined organic
layers were concentrated to dryness in vacuo, and the resulting extract was
redissolved in 200 ml methanol. Purification was conducted on an ultra-fast
liquid chromatography (UFLC) system (Shimadzu) equipped with a Nucleodur
Sphinx RP column (Macherey & Nagel; 250 3 10 mm; 5 mm pore diameter).
13C-labeled micacocidin was chromatographed with a linear gradient of
acetonitrile in water plus 0.1% trifluoroacetic acid (10%/ 90% acetonitrile
within 20 min; flow rate, 3 ml/min) with wavelength detection at 254 nm. For
nuclear magnetic resonance (NMR)-based analysis, the Ga3+-complex of mi-
cacocidin was prepared. A methanolic solution of the purified natural product
was treated with a 10-fold excess of Ga(III) nitrate hydrate and stirred for 12 hr
at room temperature. Subsequently, NMR spectra were recorded at 300 K on
a Bruker Avance III 600 MHz spectrometer using methanol-d4 as a solvent
and internal standard (dH 3.31 ppm; dC 49.0 ppm).768 Chemistry & Biology 20, 764–771, June 20, 2013 ª2013 ElsevierConstruction of the Expression Plasmid pHiK007
A gene fragment ofmicC covering the entire loadingmodule region was ampli-
fied by PCR from genomic DNA of R. solanacearum GMI1000 with the primers
P1 and P2 (a complete list with all primers used in this study is given in
Table S1). The reaction (50 ml total volume) included 2 mM MgSO4, 0.2 mM
each dNTP, 5% dimethyl sulfoxide, 50 pmol each primer, and 1.25 U Pfu
DNA polymerase. Thermal cycling conditions were as follows: initial denatur-
ation, 5 min, 95C; amplification, 30 cycles (95C for 1 min, 65C for 1 min,
72C for 7 min); final extension, 20 min at 72C, terminal hold at 4C. The
PCR product was cloned into the NdeI-HindIII site of the expression plasmid
pET28a(+) (Novagen) to give pHiK007. This vector was introduced into
E. coli KRX (Promega) after the accuracy of the inserted nucleotide sequence
had been confirmed by DNA sequencing.
Expression and Purification of the Loading Module of MicC: A1-ACP
The overexpression strain was cultured at 37C in TB medium (containing
50 mg/ml kanamycin) to an optical density at 600 nm (OD600) of 0.6. To induce
gene expression, 0.1% rhamnose was added to the culture. Following induc-
tion, fermentation was continued at 16C for 20 hr. After centrifugation, the
cell pellet was resuspended in lysis buffer (50 mM NaH2PO4, 300 mM NaCl,
10 mM imidazole, 20 mM b-mercaptoethanol, 10% glycerol) and subjected to
sonication. The cell debris was subsequently removed by centrifugation, and
the supernatantwas loadedon to a nickel-nitriloacetic acid column. The recom-
binant protein was eluted using lysis buffer containing increasing concentra-
tions of imidazole. Fractions that contained the target protein were identified
via SDS-PAGE, desalted with PD-10 columns (GE Healthcare), and concen-
trated using Amicon ultracentrifugation devices (Millipore). The recombinant
protein was finally purified by FPLC (Amersham A¨KTAexplorer) using a 5 ml Hi-
TrapQHPcolumn (GEHealthcare). The solvents usedwere20mMTris-HCl, pH
8.0, + 5%glycerol (A) and 20mMTris-HCl, pH8.0, + 5%glycerol + 1MNaCl (B).
Prior to injection of the sample, the column was washed with 20 ml 100% sol-
vent A. After injection, a linear gradient elution up to 100%of solvent Bwas car-
ried out. The separation was monitored via UV absorbance at 220 and 280 nm,
as well as by conductivity. The identity of the purified protein was confirmed by
MALDI-TOF MS using a Bruker Ultraflex spectrometer (Bruker Daltonics).
ATP-[32P]-Pyrophosphate Exchange Assay
The substrate preference of MicC (A1-ACP) was determined according to an
established protocol (Kreutzer et al., 2012). A 100 ml reaction contained
80 mM Tris-HCl (pH 7.5), 5 mM MgCl2, 5 mM ATP, 100 nM purified enzyme,
0.1 mM [32P]-pyrophosphate, and 1 mM substrate. Reactions were initiated
by addition of enzyme and incubated at 37C for 30 min prior to quenching
with 500 ml of charcoal suspension (1% charcoal and 4.5% Na4P2O7 in 3.5%
perchloric acid). Precipitate was collected with paper filter discs under vac-
uum. Following three consecutive washing steps with 40 mM Na4P2O7 in
1.4% perchloric acid (200 ml), water (200 ml), and ethanol (200 ml), the filter
papers were added to 2.5ml of scintillation fluid. Radioactivity was determined
in a Beckman Coulter LS6500 Multipurpose Scintillation Counter. All assays
were run in triplicate.
Heterologous Biosynthesis of PSA
The vector to produce the first twomodules of MicC (A1-ACP-KS-AT-KR-ACP)
was assembled from four discrete plasmids (Figure S3). In the first step, threeLtd All rights reserved
Figure 5. Model for the Product Formation in E. coli Coexpressing micA and micC (A1-ACP-KS-AT-KR-ACP)
Route A is consistent with the initiation of micacocidin biosynthesis except for the premature offload of the thioester-bound intermediate. Route B shows the
shunt pathway of KR-mutated MicC.
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P3 and P4, P5 and P6, and P7 and P8. The resulting PCR products were indi-
vidually cloned into pJET1.2 (Thermo Scientific) to give pHiK008a, pHiK008b,
and pHiK008c, respectively. All plasmids were sequenced to verify the fidelity
of their inserts. The 1.8 kb MluI-SmaI fragment from pHiK008a was inserted
into the MluI-NruI sites of pHiK008b yielding pHiK008ab, while pHiK008c
was digested with XhoI. The 1.2 kb XhoI fragment was cloned into
pET28a(+) to give pHiK008c1. The latter was opened with NdeI-NheI and sub-
sequently merged with a pHiK007-derived plasmid, in which the HindIII site
had been removed by blunting to generate an additional NheI site. This
approach yielded pHiK008c2. Finally, pHiK008ab and pHiK008c2 were com-
bined by l Red-mediated in vivo cloning to give pHiK008 (Zhang et al.,
2000). To this end, the BglII-digested pHiK008ab and the EcoRI-HindIII-
digested pHiK008c2 were used to cotransform l red-induced BW25113/
pIJ790 electrocompetent cells. The overexpression host E. coli BL21(DE3)
(Novagen) was finally transformed with the resulting construct pHiK008.
The PPTase gene micA was amplified by PCR from genomic DNA of
R. solanacearum GMI1000 with the primers P9 and P10. The PCR product
was cloned into pJET1.2, yielding pHiK009a (micA). After the correct sequence
had been confirmed by DNA sequencing, the plasmid was digested with NdeI
and EcoRV. The resulting fragment, which contained the PPTase gene, was
cloned into pACYCDuet-1 (Novagen) to give pHiK009 (micA). Subsequently,
E. coli BL21(DE3) harboring pHiK008 was transformed with pHiK009 to
generate the required strain for the coexpression experiment. For the analysis
of product formation, the E. coli strains were grown at 37C in TBmedium to an
OD600 of 0.6. Expression of micC and the PPTase gene was induced by
addition of 1 mM isopropyl 1-thio-b-D-galactopyranoside. Afterward, the incu-
bation was continued at 16C overnight. To enable the recovery of acidic
metabolites (e.g., PSA), the resulting culture broths were adjusted to pH 2 prior
to extraction with ethyl acetate. After evaporation of the organic solvent, theChemistry & Biology 20,crude extracts were resuspended inmethanol and subjected to HPLC-electro-
spray ionization (ESI)-MS analysis on an Exactive Orbitrap (Thermo Fisher
Scientific). The chromatographic system was equipped with a Betasil 100-3
C18 column (150 3 2.1 mm, 3 mm pore diameter), and separation was per-
formed using a gradient elution of acetonitrile in water plus 0.1% formic acid
(5%/ 98% acetonitrile within 15 min; flow rate, 0.2 ml/min). Extracted ions
were detected in the negative mode for the ranges m/z 206.5–207.5 (PSA, 2)
andm/z 222.5–223.5 (pyrone, 3 and olivetolic acid, 4), respectively. The result-
ing peaks were analyzed within a 5 ppm range for the accurate masses of 2, 3,
and 4. In order to discriminate between the constitutional isomers 3 and 4, the
samples were cochromatographed with 1 mmol of commercial 4 (THC Pharm).
Site-Directed Mutagenesis of the TE Domain in MicA
The desired S417Amutationwas introduced by PCRwith primers P11 and P12
using pHiK009 as a template. This approach yielded a mutated plasmid con-
taining staggered nicks (pHiK010a), which was introduced into E. coli DH5a
after the parental DNA template had been removed by DpnI digestion. The
mutation in the active site was subsequently confirmed by DNA sequencing.
To ensure that no further PCR-induced random mutation is present in the final
expression plasmid, the verified 1.3 kb SfiI-EcoRV fragment of pHiK010a with
the S417A mutation was cloned into the original vector pHiK009. The resulting
plasmid, pHiK010, was then used for the transformation of the E. coli
BL21(DE3) strain harboring pHiK008.
Inactivation ofmicA by Insertional Mutagenesis
A 2.0 kb gene fragment of micA was amplified by PCR from R. solanacearum
GMI1000 genomic DNA with primers P13 and P14. The PCR product was
blunt-end cloned into pJET1.2 to give pHiK011a. After the correct sequence
had been confirmed by DNA sequencing, the sacB gene was cloned into
pHiK011a to yield pHiK011b. The latter was used to transform E. coli764–771, June 20, 2013 ª2013 Elsevier Ltd All rights reserved 769
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An iPKS Initiates Micacocidin AssemblyBW25113 harboring pIJ790 (Gust et al., 2003). Insertion of a kanamycin-resis-
tance gene into themicA sequence was achieved by l Red-mediated recom-
bination. For this purpose, the antibiotic resistance cassette was amplified
from pAphA-3 by PCRwith the primer pair P15 and P16, generating extensions
homologous to the target micA sequence at either end of the marker. E. coli
BW25113/pIJ790/HiK011b was transformed with the PCR product following
induction of l Red genes with 10 mM L-arabinose at 30C for 3 hr. After recov-
ery in Super Optimal Broth with Catabolite repression (SOC) medium (2% tryp-
tone, 0.5% yeast extract, 20 mM glucose, 10 mM NaCl, 2.5 mM KCl, 10 mM
MgCl2) and a 1 hr incubation at 37
C, the transformants were spread on to
LB agar plates containing 50 mg/ml kanamycin, followed by incubation
overnight at 37C. Integration of the marker in the plasmid DNA by homolo-
gous recombination yielded the micA disruption plasmid pHiK011, which
was isolated and verified by PCR analysis. For the transformation of
R. solanacearum GMI1000, cells were grown in 1/4 3 M63 medium supple-
mented with 0.2% glucose and 0.4% glycerol to an optical density at 580
nm (OD580) of 0.5. After centrifugation, the harvested cells were successively
washed with sterile Milli-Q water and ice-cold 10% glycerol. Electroporation
was carried out in a 0.2 cm gap cuvette using a Bio-Rad GenePulser II set to
200U, 25 mF, and 2.5 kV. SOCmediumwas immediately added to the shocked
cells, which were then incubated at 30C for 3 hr. The resulting culture was
spread on to LB agar containing 25 mg/ml kanamycin, followed by incubation
at 30C. The mutation was verified by colony PCR (Figure S5). Micacocidin
production of themicA-defective strain RS7 was analyzed on an HPLC-diode
array detector (Agilent 1100 series) equippedwith a C8 column (Zorbax Eclipse
XDB, 150 3 4.6 mm, 5 mm pore diameter) and coupled to a mass-selective
detector with ion trap (MSD Trap; Agilent) operating in alternating ionization
mode. Separation was achieved with a linear gradient of methanol in
water plus 0.1% formic acid (10% / 90% methanol within 15 min; flow
rate, 1 ml/min) with wavelength detection at 254 nm.
Construction of the KR Domain Mutant Strains
Site-directed mutagenesis was performed on the truncated micC gene in
pHiK008c1. The desired mutations were introduced by PCR using the primers
P17 and P18 for the Y1991A mutant or P19 and P18 for the Y1991F mutant.
Following the PCR reaction, the methylated parental DNA template was
digested with DpnI. The remaining circular, nicked double-stranded DNA car-
rying the mutation was used to transform E. coli DH5a. After the correct
sequences had been confirmed by DNA sequencing, the plasmids were
digested with HincII to obtain the 0.5 kb nucleotide sequences that contained
the mutated region. These fragments were cloned into the corresponding re-
gion of pHiK008 to give pHiK012 (Y1991F) and pHiK013 (Y1991A), which
were used in the heterologous expression experiments.
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